Keith Ho, MBA, MS

Keith Ho is the Director of Clinical Innovation and Optimization within the clinical operations organization and the co-lead for the Trial Inclusiveness and Diversity Initiative at Jazz Pharmaceuticals. In his role, his objective is to develop an enterprise-level trial inclusiveness and diversity strategy and to implement associated tactics to meet regulatory mandate. His vision is to ensure Jazz’s clinical trials will reflect the populations affected by the disease, and those intended to utilize the interventions. He is also responsible for identifying innovative approaches, method, and technologies to address different clinical trial needs. Previously, Keith was at various pharmaceutical companies with roles in R&D, commercial, medical, and corporate strategy.